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Conclusions: This is the ﬁrst study to demonstrate that higher BMD in
men and women is associated with tibiofemoral cartilage loss on MRI
in knees without RKOA, including K-L grade 0 knees. We also conﬁrm
previous ﬁndings from radiographs in this cohort that BMD is weakly,
or not all, associated with structural progression in knees with existing
RKOA.
Table. BMD quartiles and relative risk of cartilage loss, by baseline K-L grade
Baseline K-L 0−1 Baseline K-L 2−3
N (%) of
subregions
with CL
RR (95%CI)
for CL
N (%) of
subregions
with CL
RR (95%CI)
for CL
FN BMD quartile
Q1-lowest 39 (3.9) 1.0 ref 61 (7.4) 1.0 ref
Q2 75 (7.7) 2.0 (1.1, 3.8) 60 (6.8) 1.0 (0.6, 1.6)
Q3 49 (5.4) 1.3 (0.7, 2.7) 93 (9.8) 1.4 (0.9, 2.2)
Q4-highest 73 (7.5) 2.1 (1.1, 4.1) 80 (9.2) 1.4 (0.9, 2.2)
P-value trend 0.084 0.080
Q 2−4 vs Q1 197 (6.9) 1.8 (1.03, 3.2) 233 (8.6) 1.2 (0.8, 1.8)
Whole body BMD quartile
Q1-lowest 37 (4.2) 1.0 ref 68 (7.3) 1.0 ref
Q2 59 (5.5) 1.4 (0.7, 2.6) 73 (9.6) 1.3 (0.8, 2.0)
Q3 60 (6.1) 1.6 (0.9, 3.1) 73 (8.5) 1.2 (0.7, 1.8)
Q4-highest 80 (8.9) 2.5 (1.3, 4.7) 77 (8.2) 1.1 (0.7, 1.8)
P-value trend 0.001 0.791
Q 2−4 vs Q1 199 (6.7) 1.7 (1.05, 3.0) 223 (8.7) 1.2 (0.8, 1.8)
319 PREVENTION OF KNEE OSTEOARTHRITIS IN OVERWEIGHT
FEMALES; FROM FEASIBILITY TRIAL TO FULL-SCALE
TRIAL
J. Runhaar1, M. van Middelkoop1, R. Steens2, D. Vroegindeweij2,
G. van Osch1, M. Reijman1, B. Koes1, S. Bierma-Zeinstra1. 1Erasmus
MC, Rotterdam, NETHERLANDS, 2Medical Center Rijnmond – Zuid,
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Purpose: In the present study we will test the preventive effect of a tailor
made intervention for reducing weight as well as of an intervention with
oral crystalline glucosamine sulphate in a factorial design in a high-risk
group of overweight middle aged women who have not yet consulted for
knee osteoarthritis (OA).
Methods: 40 general practitioners (GPs) will contact all registered women
between 50 and 60 years of age without major co-morbidities. After
telephonic screening, 400 women with a BMI  27 who have not yet
consulted for knee pain will be included in this study. At baseline, X-rays
and MRIs will be made of both knees to measure presence and amount of
OA features. Presence of radiological signs indicating knee OA (Kellgren-
Lawrence index of 2 or more) and knee OA according to the ACR criteria
are exclusion criteria. From serum and urine samples serum glucose,
serum cholesterol, levels of bone and cartilage degeneration markers and
inﬂammation markers will be determined. Through physical examination
weight, length, blood pressure, skin fold, pain on pressure of the joint
margins, and crepitation of the knee joint will be measured. All participants
ﬁll in a questionnaire to measure knee complaints (WOMAC), activity level
(SQUASH), menopausal status, co-morbidity, medical consumption, co-
interventions, and quality of live (Euroqol).
After baseline measurements, participants will be randomised over four
groups. Half of all participants will be allocated to a tailor made interven-
tion of half a year to reduce weight (consisting of physical activity classes
and several consultations with a dietician); the other half will not receive
this intervention. Secondly, in both groups half of the participants will
be randomised to receive 1500mg oral crystalline glucosamine sulphate
once a day for two and a half year while the other half will receive
a placebo. After two and a half year, baseline measurements will be
repeated. The full-scale trial was preceded by a pilot trial. In this feasibility
trial procedures, compliance and effects of the intervention were tested
during a one year follow-up.
Results: 1365 women were contacted by 10 GPs. Of these 353 women
returned a response to our research centre (26%). 184 were excluded
after telephonic screening because they did not meet the inclusion criteria
(52%). Of the remaining 93 (55%) were willing to participate and were
included in the study and followed for one year according the above-
mentioned protocol.
After 6 months, 89% of the participants had taken more than 75% of the
glucosamine or placebo. At the end of the feasibility study, 73% of the
women allocated to the tailor made intervention have visited the physical
activity classes and 84% of them had al least one consultation with the
dietician. 28% of the women in the weight reduction group showed a
weight reduction of 5 kg and/or 5% reduction of the baseline weight
versus 13% in the other group. At one year, only 4% is lost to follow-
up. On the baseline MRIs, 20% of the women showed osteochondral
defects on the patella and 10% on the medial and lateral condyle of the
femur. Osteophytes were found on the patella and on the lateral and
medial condyle of the femur (all in 10% of the women). Over 50% of the
women showed degeneration of the medial meniscus and 35% of the
lateral meniscus. At one year follow-up, 5% of the cases or less showed
progression of the knee OA related features on the MRIs.
Conclusions: Based on the results of the pilot trial, a full-scale trial
seems to be feasible. Therefore all participants of the pilot trial will be
followed for another one and a half year and 307 new participants will be
gathered according to above-mentioned protocol.
320 SELF-REPORTED ADHERENCE TO CHONDROPROTECTIVE
REGIMEN IN OSTEOARTHRITIS
G. Rovetta III1, S. Paolo2, P. Monteforte3, A. Brignone4. 1University of
Genova, Genova, ITALY , 2Fondazione Maugeri Nervi, Genova, ITALY,
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Purpose: The objective of our study was to explore the (OA) of the knee,
hip, hand, and in vertebral OA.
Methods: We performed a retrospective study involving 497 patients
who did receive a chondroprotective treatment [Glucosamine 500mg +
Chondroitin-sulphate (CSbBio-ActiveTM) 500mg), and native collagen
type II (1mg) once a day] for their painful osteoarthritis during 12 months.
Knee OA was present in 234 pts, hip OA in 78, hand OA in 124, cervical
OA in 26 and lumbar OA in 35 pts. For deﬁning treatment adherence
levels, a self reported information recorded on patient’s ﬁle was examined
and a cut-off of 70% was established.
Adherence to chondroprotective treatment in OA.
Results: During the 12 months of observation, the level of adherence
>70% was maintained for 22/78 of hip OA, 185/234 for knee OA, 10/26
for cervical OA, 15/35 for lumbar OA and 98/124 for hand OA; the overall
number of adherents was 330 and 167 discontinued the chondroprotec-
tive treatment. Patients affected with peripheral OA did maintain the >70%
treatment adherence greater than pts with vertebral OA (p> 0.01). The
difference between hip sufferers and knee sufferers was signiﬁcant. The
difference between hand and knee sufferers was not signiﬁcant.
Conclusions: People who are prescribed self-administered medications
generally take less than the prescribed doses. Increasing adherence to
medications might improve the beneﬁts, but also might increase adverse
effects of medications. This is not the case of chondroprotective treat-
ment, which has in toxicology studies an excellent tolerance proﬁle. In our
observation, a quite satisfactory adherence was present only in sufferers
of knee OA and hand OA. Ameliorating adherence may possibly improve
patient outcomes.
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Purpose: To estimate the average cost per patient with osteoarthritis,
treated with CS or NSAID for 6 months, and the possible consequences
that the reduction on the consumption of NSAID due to CS treatment
may have on the budget impact for the Spanish National Health System
(NHS).
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Methods: A retrospective study from 530 osteoarthritic patients, treated
with CS or NSAID was performed to determine the consumption of health
resources. The results obtained were used in a cost-minimization model
that compared both treatments, used at the recommended doses and
regimens during a six-month period. Effectiveness and the incidence of
adverse events were estimated from meta-analyses based on randomized
clinical trials. Simple univariate sensitivity analysis was performed from
the basic case.
Results: The overall six-month cost per patient treated with CS or
NSAID was 144€ and 192€, respectively. If in the upcoming 3 years,
the treatment of the patients currently treated with NSAID was replaced
gradually in 5%, 10% and 15% by CS, the expected savings to the NHS
during these 3 years would be over 45 million €. In addition, 2.666 cases
of gastrointestinal adverse events (including 90 serious adverse events),
as well as 5 myocardial infarction episodes, would be avoided for every
10.000 patients treated with CS instead of NSAID. Sensitivity analysis
conﬁrmed the strength of the basic case in all of the scenarios.
Conclusions: Chondroitin sulfate is a more efﬁcient treatment for os-
teoarthritis, with less costs and better gastrointestinal tolerance, than
NSAID.
322 THE NATURAL HISTORY OF PHYSICAL ACTIVITY UP
TO TWELVE MONTHS AFTER PRIMARY TOTAL KNEE
ARTHROPLASTY FOR OSTEOARTHRITIS
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Purpose: This prospective cohort study compared the natural history
of physical activity (PA) over a 12-month period in 2 cohorts with knee
osteoarthritis (OA), one undergoing primary total knee arthroplasty (TKA
Cohort) and one not undergoing TKA (Non-TKA Cohort).
Methods: All patients were aged 45 years or older. Sociodemographic
factors, clinical factors, and PA levels were assessed by structured
interviews at baseline and at 3, 6, 9, and 12 months after TKA. Self-
administered questionnaires assessed health status at baseline and at
6 and 12 months after TKA. Sociodemographic factors included gender,
age, race/ethnicity, marital status, income, and education. Clinical factors
included knee OA severity (Index of Severity for Knee Disease), knee
pain intensity (Visual Analogue Scale), comorbidities (Charlson Index),
and body mass index. The SF-36 and WOMAC were used to determine
general and disease-speciﬁc health status, respectively. The Historical
Leisure and Modiﬁable Activity Questionnaires were used to assess past-
month total PA (leisure and occupational activity combined) at each time
point. The season of the year when data were collected was also docu-
mented. Generalized linear models were constructed using a hierarchical
method to identify signiﬁcant predictors of total PA at time points for which
all data were available (baseline, 6 months, and 12 months). A repeated
measures mixed model approach determined the predictor variables in
the ﬁnal model.
Results: In the TKA Cohort, 83 (61.4% female) of 90 patients
(92.2%) (mean±SD age 66.6±9.7 years) completed the study. Eighty-
two (75.6% female) of 92 patients (89.1%) in the Non-TKA Cohort (mean
age 68.6±10.4 years) completed the study. At baseline, the TKA Cohort
was less educated, and reported greater disease severity and lower
general health status than the Non-TKA Cohort. The TKA Cohort reported
24.3, 41.4, 46.2, 56, and 52.5 median MET-hours per week of total
PA at baseline and at 3, 6, 9, and 12 months, respectively. The Non-
TKA Cohort reported 37.4, 41.4, 43.1, 40.2, and 40.8 MET-hours per
week at the same time points. Total PA in the TKA Cohort was lower
at baseline (p< 0.01), similar at 3 and 6 months, and higher at 9 and
12 months (p< 0.05) than the Non-TKA Cohort. In unadjusted analyses,
although total PA increased signiﬁcantly in the TKA Cohort from baseline
to 12 months, there was no change in the Non-TKA Cohort during the
same time period. After adjusting for the effects of the other variables in
the model, the predictors of greater total PA over the 12 months were
male gender (regression coefﬁcient b [% change] = 35.1%, p< 0.001),
graduation from high school versus any other educational level (b ranged
from −38.6% to −20.7%, p = 0.02), autumn season versus any other
season (b ranged from −17.6% to 9.4%, p = 0.005), the ability to ambulate
without an assistive device (b = 34.3%, p< 0.001), higher physical function
(b = 0.82%, p< 0.001) and vitality (b = 0.59%, p = 0.002), and time since
baseline (6 months b = 19.7%, p = 0.003; 12 months b = 15.9%, p = 0.03).
Cohort status was not a signiﬁcant predictor of total PA in the ﬁnal model.
Conclusions: As far as we know, this was the ﬁrst study to examine the
natural history of PA after primary TKA for OA. As expected, individuals
immediately prior to TKA had lower levels of total PA than those not
having surgery. In the ﬁnal model, total PA did not vary based on whether
or not a person underwent TKA. In both cohorts, total PA increased by
19.7% at 6 months and 15.9% at 12 months as compared to baseline.
Future studies could focus on tailoring PA interventions to people after
TKA based on our knowledge of the natural history of PA.
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PERSON-BASED WOMAC PHYSICAL FUNCTION SCORES:
DATA FROM THE OSTEOARTHRITIS INITIATIVE
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Purpose: In clinical trials of knee OA and imaging biomarker studies,
physical function outcomes are often assessed for an index, or study,
knee. The relationship between difﬁculty with physical activities attributed
to a speciﬁc knee and the overall effect of both knees on the level of difﬁ-
culty perceived by an individual has not been studied. We examined the
relationship between bilateral knee-speciﬁc and person-based physical
function assessed using the WOMAC function subscale.
Methods: Subjects were 133 men and women (52%) enrolled in the
Osteoarthitis Initiative, mean (SD) age 61 (9.4) who were interviewed
twice on the same day, once using a knee-speciﬁc (“. . . how much
difﬁculty do you have due to pain, discomfort or arthritis in your right
knee . . . ”) and once using a person-centered version (“. . . due to pain,
discomfort or arthritis in either of your knees . . . ”) of the WOMAC physical
function subscale (WOMACTM Likert 3.1). One half of subjects were
asked the knee-speciﬁc version ﬁrst and, after at least one hour, were
asked the person-based version, with this order reversed for the rest of
the sample. We calculated a person-level difﬁculty score from the two
knee-speciﬁc scores for an item in two ways, (1) taking the worse of the
two knees and (2) taking the average for the two knees, then for both
methods summing over items for a total score. We compared these two
calculated total scores to the total score from the person-based version.
Table 1: Correlation of person-based function subscale scores derived from knee-speciﬁc vs.
person versions
All
subjects
Subjects with
some difﬁculty
Subjects with
unilateral difﬁculty
Subjects with
bilateral difﬁculty
Person score calculated using
‘worse’ of 2 knee scores for item
0.94 0.91 0.90 0.90
Person score calculated using
mean of 2 knee scores for item
0.90 0.86 0.90 0.86
Results: 71% of participants had some difﬁculty in physical function on
one or more WOMAC items. For a given item, relationships between
the two knee-speciﬁc responses and the person-based response fell
into several patterns. Of all nonzero response sets (some difﬁculty in
either knee or at the person level), 14% indicated greater difﬁculty for
both knees than for the person, 10% less difﬁculty for both knees than
